Investigating the response to COVID-19 and understanding severe TB cases: The 2022 Pulmonology TB series.

Migliori, G B; Tiberi, S; Duarte, R

Migliori, G B; Tiberi, S; Duarte, R.

Migliori GB; Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Via Roncaccio 16, Tradate, Tradate, Varese 21049, Italy. Electronic address: giovannibattista.migliori@icsmaugeri.it.
Tiberi S; Department of Infection, The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University, London, United Kingdom.
Duarte R; ICBAS-UP, Instituto de Ciências Biomédicas de Abel Salazar, Universidade do Porto, Portugal; ISPUP, Instituto de Saúde Pública da Universidade do Porto, Portugal; Unidade de Investigação Clínica, Administração Regional de Saúde do Norte, Portugal; Serviço de Pneumologia, Centro Hospitalar de Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal.

Pulmonology ; 28(3): 155-157, 2022.

Article in English | MEDLINE | ID: covidwho-1671072

Subject(s)

COVID-19; Pulmonary Medicine; Tuberculosis; Humans; SARS-CoV-2; Tuberculosis/diagnosis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Tuberculosis / Pulmonary Medicine / COVID-19 Type of study: Diagnostic study Limits: Humans Language: English Journal: Pulmonology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google